Dynamic Advisor Solutions LLC Has $220,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Dynamic Advisor Solutions LLC trimmed its position in ARK Genomic Revolution ETF (BATS:ARKG) by 14.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,588 shares of the company’s stock after selling 1,802 shares during the period. Dynamic Advisor Solutions LLC’s holdings in ARK Genomic Revolution ETF were worth $220,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ARKG. SG Americas Securities LLC raised its holdings in ARK Genomic Revolution ETF by 360.9% during the 1st quarter. SG Americas Securities LLC now owns 143,288 shares of the company’s stock worth $2,975,000 after buying an additional 112,201 shares during the period. Prospect Financial Services LLC raised its holdings in ARK Genomic Revolution ETF by 10.3% during the 1st quarter. Prospect Financial Services LLC now owns 13,654 shares of the company’s stock worth $283,000 after buying an additional 1,273 shares during the period. NBC Securities Inc. raised its holdings in ARK Genomic Revolution ETF by 137,400.0% during the 1st quarter. NBC Securities Inc. now owns 1,375 shares of the company’s stock worth $28,000 after buying an additional 1,374 shares during the period. Alpha Wealth Funds LLC acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth approximately $471,000. Finally, Capital A Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth approximately $60,000.

ARK Genomic Revolution ETF Stock Up 2.3%

Shares of ARKG opened at $24.15 on Friday. ARK Genomic Revolution ETF has a twelve month low of $17.51 and a twelve month high of $31.16. The company has a 50 day moving average of $21.98 and a 200-day moving average of $23.65.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.